International Clinical Trial: Clinical Application Research of Serum Amyloid A1 as a Biomarker for Sepsis-Associated Acute Respiratory Distress Syndrome

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118255) titled 'Clinical Application Research of Serum Amyloid A1 as a Biomarker for Sepsis-Associated Acute Respiratory Distress Syndrome' on Feb. 3.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Chongqing Emergency Medical Center

Condition: Sepsis-associated acute lung injury,Sepsis-associated acute respiratory distress syndrome

Intervention: Case Group:None

Recruitment Status: Not Recruiting

Phase: 0

Date of First Enrollment: 2026-02-15

Target Sample Size: Case Group:62;control group:62;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?pro...